ERCP and SARS-COV-2: an urgent procedure that should be immune.
Age Factors
Aged
Aged, 80 and over
COVID-19
Cholangiopancreatography, Endoscopic Retrograde
/ methods
Cohort Studies
Coronavirus Infections
/ epidemiology
Cross Infection
/ epidemiology
Databases, Factual
Female
Humans
Incidence
Infection Control
/ organization & administration
Male
Middle Aged
Pandemics
/ prevention & control
Pneumonia, Viral
/ epidemiology
Reference Values
Referral and Consultation
/ statistics & numerical data
Retrospective Studies
Risk Assessment
Sex Factors
COVID-19
Endoscopic retrograde cholangio-pancreatographies
SARS-COV-2
referral difficulties and changes
urgent
Journal
Scandinavian journal of gastroenterology
ISSN: 1502-7708
Titre abrégé: Scand J Gastroenterol
Pays: England
ID NLM: 0060105
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
10
7
2020
medline:
1
9
2020
entrez:
10
7
2020
Statut:
ppublish
Résumé
Radical changes to clinical and endoscopy practice have been rapidly introduced following the spread of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Urgent endoscopies are, however, intended to proceed as normal with additional personal protective procedures. A perceived reduction in hospital attendances may suggest a number of urgently indicated endoscopic retrograde cholangio-pancreatographies (ERCPs) are being missed. Under service restrictions (13 March to the end of April 2020), 55 ERCPs were performed compared with 87 ERCPs in 2019. Similar numbers to 2019 were also recorded in the preceding years. One case of coronavirus disease 2019 (COVID-19) was reported in a patient in the days following ERCP, with no cases notified among staff related to endoscopy. A reduction in ERCP referrals raises concern that a cohort of patients with significant biliary disease remain undetected. Whether this results in later, and more severe, presentation remains to be seen but a potential surge in such cases could significantly burden all future endoscopy planning services.
Sections du résumé
BACKGROUND
Radical changes to clinical and endoscopy practice have been rapidly introduced following the spread of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Urgent endoscopies are, however, intended to proceed as normal with additional personal protective procedures. A perceived reduction in hospital attendances may suggest a number of urgently indicated endoscopic retrograde cholangio-pancreatographies (ERCPs) are being missed.
RESULTS
Under service restrictions (13 March to the end of April 2020), 55 ERCPs were performed compared with 87 ERCPs in 2019. Similar numbers to 2019 were also recorded in the preceding years. One case of coronavirus disease 2019 (COVID-19) was reported in a patient in the days following ERCP, with no cases notified among staff related to endoscopy.
CONCLUSIONS
A reduction in ERCP referrals raises concern that a cohort of patients with significant biliary disease remain undetected. Whether this results in later, and more severe, presentation remains to be seen but a potential surge in such cases could significantly burden all future endoscopy planning services.
Identifiants
pubmed: 32643467
doi: 10.1080/00365521.2020.1789210
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM